RefleXion Medical is a privately held biotargeting oncology company headquartered in Hayward, CA. The RefleXion™ X1 machine is now available for sale. The RefleXion™ X1 BgRT capability requires 510(k) clearance; this feature is not available for sale.
Location: United States, California, Hayward
Employees: 51-200
Total raised: $581.6M
Founded date: 2009
Investors 7
| Date | Name | Website |
| - | The Rise F... | therisefun... |
| - | KCK Medtec... | kckmedtech... |
| - | Sofinnova ... | sofinnovap... |
| - | Exor | exor.com |
| 12.04.2022 | Ascension ... | ascensionv... |
| - | Catalio Ca... | cataliocap... |
| - | TPG | tpg.com |
Funding Rounds 7
| Date | Series | Amount | Investors |
| 15.11.2023 | - | $105M | - |
| 06.07.2022 | - | $125M | - |
| 10.03.2022 | - | $80M | - |
| 16.04.2020 | - | $100M | - |
| 02.05.2019 | - | $60M | - |
| 08.04.2018 | Series C | $100M | - |
| 04.04.2014 | - | $11.6M | - |
Mentions in press and media 23
| Date | Title | Description |
| 16.11.2023 | RefleXion Holds Initial Close of $105M Funding | RefleXion, a Hayward, CA-based therapeutic oncology company, raised $105M in funding. The round was led by The Rise Fund, with participation from Ally Bridge, Pfizer Ventures and Johnson & Johnson Innovation (JJDC Inc.), T.Rowe Price As... |
| 15.11.2023 | PET-guided radiotherapy green light in hand, RefleXion raises $105M for commercial push | After winning an FDA clearance earlier this year for its image-guided radiation treatment for cancer, RefleXion Medical has raised $105 million to boost commercialization efforts as well as develop new applications for its approach. The equ... |
| 08.07.2022 | RefleXion Medical Raises $125M for Biology-Guided Radiotherapy | What You Should Know: – RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT) for all stages of cancer, today announced the closing of a $125M debt facility, of which $55M is available im... |
| 06.07.2022 | RefleXion Closes $125M Debt Facility | RefleXion Medical, a Hayward, CA-based therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT) for all stages of cancer, closed a $125M debt facility led by Oxford Finance. $55M is available immediately to repa... |
| 10.06.2022 | Telix and RefleXion Expand Partnership for Prostate Cancer Treatment | MELBOURNE, Australia and INDIANAPOLIS, June 10, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and RefleXion Medical, Inc. (Hayward, California, U.S.) (RefleXion) today announced the signing of a co-develo... |
| 11.03.2022 | RefleXion collects $80M after scoring breakthrough tag for its PET-guided radiotherapy | Targeted radiotherapy company RefleXion Medical has raised $80 million to help broaden its cancer offerings after recently exploring the company’s potential in treating prostate cancer and other tumors. The new venture capital funding follo... |
| 10.03.2022 | RefleXion Raises $80M in Funding | RefleXion Medical, a Hayward, Calif.-based therapeutic oncology company, closed an $80m equity financing. In addition to participation from existing investors TPG’s The Rise Fund, KCK Group, PSP Investments, T. Rowe Price, Ally Bridge Partn... |
| 17.04.2020 | RefleXion Medical To Tap Into New $100M Financing For Cancer Therapy | 11 Shares Email Facebook Twitter LinkedIn After receiving U.S. Food and Drug Administration clearance for treatment pertaining to its RefleXion X1 machine, therapeutic oncology company RefleXion Medical has closed on a $100 million equity f... |
| 16.04.2020 | RefleXion Medical Grabs $100M | HAYWARD, CA, RefleXion Medical today announced the close of a $100 million equity financing. >> Click here for more funding data on RefleXion Medical >> To export RefleXion Medical funding data to PDF and Excel, click here ... |
| 16.04.2020 | Galapagos finds Polish partner for inflammation drugs; Zai Lab's Zejula app gets speedy review in China | → Belgium’s Galapagos and Polish biotech Ryvu are partnering on a discovery and development pact for inflammation drugs. Ryvu will do the early discovery work while Galapagos has rights to license the IP. Ryvu gets an un... |
Show more